Anavex Life Sciences presenting at Society for Neuroscience Nov. 11-15, 2017 in Washington DCNov 6, 2017Efficacy of ANAVEX 2-73, a Sigma-1 receptor agonist, in the MECP2 mouse model of Rett syndrome
Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025
